EPIUnit-Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas no. 135, 4050-600, Porto, Portugal.
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Rua de Jorge Viterbo Ferreira no. 228, 4050-313, Porto, Portugal.
J Cancer Surviv. 2020 Oct;14(5):720-730. doi: 10.1007/s11764-020-00886-8. Epub 2020 Jun 27.
To estimate the association between a cancer diagnosis and the use of healthcare services and medication among cancer survivors (CS) and their partners (PCS), particularly in the first years after diagnosis.
This is a cross-sectional study based on data from the Fourth Wave of the Survey of Health, Ageing and Retirement in Europe-SHARE (2010-2011); it included individuals aged ≥ 50 years and their partners, from 16 European countries. All CS diagnosed with a first primary cancer within 10 years (n = 1174) and corresponding PCS (n = 1174) were country-, sex-, age- and education-matched (1:3) with non-cancer individuals (NC) and partners of non-cancer individuals (PNC), respectively. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CIs) were computed.
Healthcare use in the previous 12 months and current medication intake were more frequent among CS than NC; the ORs (95% CIs) were 2.56 (2.23-2.94) for ≥ 8 medical contacts, 3.07 (2.62-3.59) for hospital stays and 1.75 (1.52-2.03) for use of ≥ 3 drugs indicated for different health problems. Medical contacts (OR = 5.74, 95% CI 4.31-7.65) and hospitals stays (OR = 13.88, 95% CI 10.15-18.98) were more frequent among CS diagnosed in the last 2 years. Contacts with medical doctors (≥ 8; OR = 1.23, 95% CI 1.06-1.42) were also more common among PCS than PNC.
When compared to individuals without cancer, CS diagnosed in the last 10 years, as well as their partners, had an increased healthcare use.
These findings highlight the importance of family-focused care in oncological settings, in order to support patients as well as their partners, who are frequently their closest significant person.
评估癌症诊断与癌症幸存者（CS）及其伴侣（PCS）使用医疗服务和药物之间的关联，特别是在诊断后的头几年。
这是一项基于欧洲第四次健康、老龄化和退休调查（SHARE）第四波数据的横断面研究（2010-2011 年）；它包括来自 16 个欧洲国家的年龄≥50 岁的个体及其伴侣。所有在 10 年内被诊断出患有第一原发癌症的 CS（n=1174）和相应的 PCS（n=1174）与非癌症个体（NC）和非癌症个体的伴侣（PNC）按国家、性别、年龄和教育程度进行匹配（1:3）。计算了调整后的优势比（OR）和 95%置信区间（95%CI）。
与 NC 相比，CS 在过去 12 个月内接受的医疗保健服务更多，服用的药物也更多；OR（95%CI）分别为接受≥8 次医疗接触（2.56[2.23-2.94]）、住院治疗（3.07[2.62-3.59]）和使用≥3 种用于不同健康问题的药物（1.75[1.52-2.03]）。在过去 2 年内被诊断出患有癌症的 CS 中，医疗接触（OR=5.74，95%CI 4.31-7.65）和住院治疗（OR=13.88，95%CI 10.15-18.98）更为频繁。与 PNC 相比，PCS 与医生的接触（≥8 次；OR=1.23，95%CI 1.06-1.42）也更为常见。
与未患癌症的个体相比，在过去 10 年内被诊断出患有癌症的 CS 及其伴侣的医疗保健使用率更高。
这些发现强调了在肿瘤学环境中以家庭为中心的护理的重要性，以便为患者及其伴侣提供支持，他们通常是患者最亲近的重要人物。
